International audienceTo identify the risk factors associated with presentation for care with CD4 cell count ≤ 200 cells/mm(3) and death in HIV-infected patients in Lyon, France. Data were analyzed on participants from mid-1992 to December 2006 in the Lyon section of the French Hospital Database on HIV Infection. Patients were stratified into two categories according to CD4 cell count at first presentation for care in University of Lyon hospitals: Group 1 (Gr1) patients with CD4 ≤ 200 cells/mm(3) and Group 2 (Gr2) patients with CD4 >200 cells/mm(3). Multivariate logistic regression assessed the risk factors associated with first presentation for care with CD4 ≤ 200 cells/mm(3). Survival was analyzed according to the Cox regression model. Am...
BACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
Background: HIV treatment and care services were scaled up in 2007 in India with objective to increa...
International audienceBACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected pe...
International audienceTo identify the risk factors associated with presentation for care with CD4 ce...
International audienceObjective: The objective of this study was to identify the factors associated ...
Summary Background Whether people living with HIV who have not received antiretroviral therapy (ART)...
BACKGROUND: CD4 cell count is a strong predictor of the subsequent risk of AIDS or death in HIV-infe...
(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as we...
Background: Evidence exists that even at high CD4 counts, mortality among HIV-infected antiretrovira...
BACKGROUND: Whether people living with HIV who have not received antiretroviral therapy (ART) and ha...
International audienceThe consensus definition of late presentation for human immunodeficiency virus...
Background: In resource-limited countries, estimating CD4-specific incidence rates of mortality and ...
OBJECTIVE: To determine the relationship between mortality risk and the CD4 cell response to antiret...
Continued debate exists about whether initiation of antiretroviral therapy (ART) in symptom-free pat...
Background: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
BACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
Background: HIV treatment and care services were scaled up in 2007 in India with objective to increa...
International audienceBACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected pe...
International audienceTo identify the risk factors associated with presentation for care with CD4 ce...
International audienceObjective: The objective of this study was to identify the factors associated ...
Summary Background Whether people living with HIV who have not received antiretroviral therapy (ART)...
BACKGROUND: CD4 cell count is a strong predictor of the subsequent risk of AIDS or death in HIV-infe...
(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as we...
Background: Evidence exists that even at high CD4 counts, mortality among HIV-infected antiretrovira...
BACKGROUND: Whether people living with HIV who have not received antiretroviral therapy (ART) and ha...
International audienceThe consensus definition of late presentation for human immunodeficiency virus...
Background: In resource-limited countries, estimating CD4-specific incidence rates of mortality and ...
OBJECTIVE: To determine the relationship between mortality risk and the CD4 cell response to antiret...
Continued debate exists about whether initiation of antiretroviral therapy (ART) in symptom-free pat...
Background: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
BACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
Background: HIV treatment and care services were scaled up in 2007 in India with objective to increa...
International audienceBACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected pe...